Dempsey Cos year-end is 30th September 2019. Dempsey Co commenced the development stage of a project to produce a new pharmaceutical drug on 1st January 2019. Expenditure of 40,000 per month was incurred until the project was completed on 30th June 2019 when the drug went into immediate production. The directors became confident of the projects success on 1st March 2019. The drug is expected to generate benefits for five years. What is the carrying amount of any intangible asset recognised in respect of the project?

152,000 154,000 150,000 148,000